Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Benitec Biopharma Q1 EPS $(2.76) Up From $(7.99) YoY

Author: Benzinga Newsdesk | November 13, 2023 09:23am
Benitec Biopharma (NASDAQ:BNTC) reported quarterly losses of $(2.76) per share. This is a 65.46 percent increase over losses of $(7.99) per share from the same period last year.

Posted In: BNTC


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist